https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-strides-pharma-cipla-recall-products-in-the-us/articleshow/93687968.cms
The USFDA noted in its report that the company, a subsidiary of Mumbai-based drug firm, is recalling the affected lot due to blister package issues. The lot was produced at Glenmark's Pithampur (Madhya Pradesh) based manufacturing facility. The USFDA stated…
Create an account or login to join the discussion